|
JAMA Oncology |
Use of an Analytics and Electronic Health Record–Based Approach for Targeted COVID-19 Vaccine Outreach to Marginalized Populations |
1 |
Yes |
8/30/2024 |
|
JAMA Oncology |
Update on the Diagnosis and Treatment of POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes) Syndrome |
1 |
Yes |
9/16/2024 |
|
JAMA Oncology |
Unilateral Leg Swelling in a Young Woman |
1 |
Yes |
9/2/2024 |
|
JAMA Oncology |
Typical Kidney Tumor With Atypical Presentation |
1 |
Yes |
6/17/2024 |
|
JAMA Oncology |
Time-Related Biases in Nonrandomized COVID-19 Era Studies Using Real-world Data |
1 |
Yes |
6/21/2024 |
|
JAMA Oncology |
Time-Dependent COVID-19 Mortality in Patients With CancerAn Updated Analysis of the On Covid Registry |
1 |
Yes |
11/24/2024 |
|
JAMA Oncology |
Time-Dependent COVID-19 Mortality in Patients With Cancer - An Updated Analysis of the On Covid Registry |
1 |
Yes |
11/24/2024 |
|
JAMA Oncology |
Subacute Abdominal Pain in a Patient With Chronic Liver Disease and Hepatocellular Carcinoma |
1 |
Yes |
9/22/2025 |
|
JAMA Oncology |
Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for Cancer |
1 |
Yes |
8/4/2024 |
|
JAMA Oncology |
SARS-CoV-2 Spike-Specific T-Cell Responses in Patients With B-Cell Depletion Who Received Chimeric Antigen Receptor T-Cell Treatments |
1 |
Yes |
11/24/2024 |
|
JAMA Oncology |
SARS-CoV-2 Antibody Response to 2 or 3 Doses of the BNT162b2 Vaccine in Patients Treated With Anticancer Agents |
1 |
Yes |
1/14/2025 |
|
JAMA Oncology |
Pancytopenia in a Patient With Metastatic Well-Differentiated Neuroendocrine Tumor After Peptide Receptor Radionuclide Therapy |
1 |
Yes |
4/29/2024 |
|
JAMA Oncology |
Painful Eruptions in a Patient With Cholangiocarcinoma Treated With Fibroblast Growth Factor Receptor Inhibitor |
1 |
Yes |
10/28/2024 |
|
JAMA Oncology |
Neoadjuvant Endocrine Therapy in Clinical Practice |
1 |
Yes |
11/18/2024 |
|
JAMA Oncology |
Management of Cutaneous Immune-Related Adverse Events in Patients With Cancer Treated With Immune Checkpoint Inhibitors |
1 |
Yes |
1/20/2025 |
|
JAMA Oncology |
Long-term Immunogenicity of BNT162b2 Vaccine in Patients With Solid Tumors |
1 |
Yes |
4/22/2025 |
|
JAMA Oncology |
Interstitial Lung Disease Induced by Anti-ERBB2 Antibody-Drug Conjugates |
1 |
Yes |
12/16/2024 |
|
JAMA Oncology |
Inhibition of SARS-CoV-2 Omicron BA.1 and BA.4 Variants After Fourth Vaccination or Tixagevimab and Cilgavimab Administration in Patients With Cancer |
1 |
Yes |
9/23/2025 |
|
JAMA Oncology |
Incidence of Axillary Adenopathy in Breast Imaging After COVID-19 Vaccination |
1 |
Yes |
8/4/2024 |
|
JAMA Oncology |
Immune Responses to SARS-CoV-2 Among Patients With Cancer - What Can Seropositivity Tell Us? |
1 |
Yes |
6/4/2024 |
